HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D J Naisbitt Selected Research

Sulfamethoxazole

8/2015HLA-DQ allele-restricted activation of nitroso sulfamethoxazole-specific CD4-positive T lymphocytes from patients with cystic fibrosis.
5/2001Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo.
2/2001Influence of reduced glutathione on the proliferative response of sulfamethoxazole-specific and sulfamethoxazole-metabolite-specific human CD4+ T-cells.
12/2000Plasma cysteine deficiency and decreased reduction of nitrososulfamethoxazole with HIV infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


D J Naisbitt Research Topics

Disease

14Hypersensitivity (Allergy)
06/2017 - 06/2000
6Drug Hypersensitivity (Drug Allergy)
08/2015 - 12/2000
3Drug-Related Side Effects and Adverse Reactions
03/2003 - 12/2000
2Drug Hypersensitivity Syndrome
02/2017 - 08/2005
2Eosinophilia
08/2005 - 03/2003
1Iatrogenic Disease
06/2017
1Tuberculosis (Tuberculoses)
02/2017
1Exanthema (Rash)
02/2017
1Chemical and Drug Induced Liver Injury
12/2015
1Cystic Fibrosis (Mucoviscidosis)
08/2015
1Neoplasms (Cancer)
09/2010
1Hyperthermia
11/2009
1Acute Liver Failure (Fulminant Hepatic Failure)
08/2005
1HIV Infections (HIV Infection)
12/2000
1Neutropenia
07/2000
1Agranulocytosis (Granulocytopenia)
07/2000
1Treatment-Resistant Schizophrenia
07/2000

Drug/Important Bio-Agent (IBA)

14Pharmaceutical PreparationsIBA
06/2017 - 06/2000
5Proteins (Proteins, Gene)FDA Link
06/2017 - 11/2000
5HaptensIBA
06/2017 - 12/2000
4SulfamethoxazoleFDA LinkGeneric
08/2015 - 12/2000
3CytokinesIBA
11/2009 - 12/2000
2LactamsIBA
06/2017 - 12/2015
2AntigensIBA
08/2015 - 01/2014
2Anticonvulsants (Antiepileptic Drugs)IBA
01/2012 - 11/2000
2Carbamazepine (Tegretol)FDA LinkGeneric
08/2005 - 03/2003
2Hydroxylamine (Hydroxylamine Hydrochloride)IBA
02/2001 - 06/2000
1PiperacillinFDA LinkGeneric
06/2017
1AntibodiesIBA
06/2017
1Immunoglobulin G (IgG)IBA
06/2017
1Isoniazid (Ftivazide)FDA LinkGeneric
02/2017
1Rifampin (Rifampicin)FDA LinkGeneric
02/2017
1PyrazinamideFDA LinkGeneric
02/2017
1Ethambutol (Myambutol)FDA LinkGeneric
02/2017
1Antitubercular AgentsIBA
12/2015
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
12/2015
1HLA-DQ Antigens (HLA-DQ)IBA
08/2015
1Anti-Bacterial Agents (Antibiotics)IBA
01/2012
1VaccinesIBA
09/2010
1Telomerase (Telomerase Reverse Transcriptase)IBA
09/2010
1InterleukinsIBA
11/2009
1Protein CIBA
11/2009
1Interferon-gamma (Interferon, gamma)IBA
11/2009
1EndotoxinsIBA
11/2009
1Complement System Proteins (Complement)IBA
11/2009
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2009
1staphylococcal enterotoxin BIBA
11/2009
1Viral ProteinsIBA
11/2009
1Dinoprostone (PGE2)FDA Link
11/2009
1Interleukin-6 (Interleukin 6)IBA
11/2009
1Transforming Growth Factor beta (TGF-beta)IBA
11/2009
1Oxidants (Oxidizing Agents)IBA
11/2009
1Buthionine SulfoximineIBA
11/2009
1LipopolysaccharidesIBA
11/2009
1Cysteine (L-Cysteine)FDA Link
12/2000
1TriazinesIBA
11/2000
1Lamotrigine (Lamictal)FDA LinkGeneric
11/2000
1Clozapine (Clozaril)FDA LinkGeneric
07/2000
1Antipsychotic Agents (Antipsychotics)IBA
07/2000

Therapy/Procedure

1Drug Therapy (Chemotherapy)
08/2001